Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving Rivaroxaban

by Antovic, J.P, Božič Mijovski, M., Malmström, R.E, Mavri, A.
Published 2022

Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation

by Gellad, W.F, Guo, J., Hernandez, I., Liang, Q., Newman, T.V, Yang, L.
Published 2021

Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases

by Abutaleb, M.H, Alammari, M., Alrowily, A., Jalal, Z., Osman, N.A, Paudyal, V.
Published 2021

Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation

by Ballarin, E., Charlton, A., Ibanez, L., Martinez, L.M.L, Sabate, M., Vidal, X.
Published 2021

Venous thromboembolism prophylaxis in patients undergoing knee replacements: comparison of real-world outcomes

by Ahmed, N., Dawoud, D., Hasan, S.S, Sunter, W., Zaidi, S.T.R
Published 2021

Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial

by Ashburner, J.M, Atlas, S.J, Borowsky, L.H, Chang, Y., Ellinor, P.T, Guan, W., Khurshid, S., Lipsanopoulos, A.T.T, Lubitz, S.A, McManus, D.D, Singer, D.E
Published 2022

Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors

by Elavalakanar, P., Miller, E.J, Neuberg, D., Patell, R., Ren, S., Southard, H., Uhlmann, E.J, Weber, G.M, Zwicker, J.I
Published 2022

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week

by Bagiella, E., Ben-Yehuda, O., Bustamante, J., Dressler, O., Farkouh, M.E, Fuster, V., Godoy, L.C, Granada, C., Granada, J.F, Lala, A., Moreno, P.R, Nadkarni, G.N, Palacios, I.F, Peyra, C., Stone, G.W, Tinuoye, E.O
Published 2022

Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study

by Harris, K.C, Kubitza, D., Lesko, L.J, Li, J.S, McCrindle, B.W, Michelson, A.D, Nessel, K., Pina, L.M, Weber, T., Willmann, S., Yang, H., Zannikos, P., Zhou, W., Zhu, P.
Published 2022

Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (...

by Amaro, A.J.J, Badimon, J.J, Berrospi, P., Bryce, A., Cobos S., L., Duran, M., Gomez-Mancebo, J.R, González, J.J.R, Lanas, F., Lara, J., Libby, P., López-Jaramillo, P., Lorenzatti, A., Lozada, A.F, Medina-Palomino, F.A, Miranda, D., Piskorz, D., Ponte-Negretti, C.I, Puente-Barragan, A., Rodrigo, A.K, Santos, R.D, Toth, P.P, Ullauri-Solórzano, V.E, Urina-Triana, M., Valdés, T.O, Villar, R., Wyss, F.S
Published 2022

Cortisol on circadian rhythm and its effect on cardiovascular system

by Abu, I.F, Azmani, S., Azmi, N.A.S.M, Das, S., Effendy, N.M, Juliana, N., Teng, N.I.M.F
Published 2021

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

by Aboyans, V., Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Chen, E., Commerford, P.J, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Ha, J.-W, Hart, R.G, Hori, M., Kakkar, A., Keltai, K., Keltai, M., Kim, J.-H, Lamy, A., Lanas, F., Lanius, V., Leong, D.P, Lewis, B.S, Liang, Y., Liu, L., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Misselwitz, F., Moayyedi, P., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J.L, Ryden, L., Sharma, M., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Varigos, J.D, Verhamme, P.B, Vinereanu, D., Widimsky, P., Yuan, F., Yusoff, K., Yusuf, S., Zhu, J.
Published 2017

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Hart, R.G, Hori, M., Kakkar, A.K, Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Cook Bruns, N., Dagenais, G.R, Dans, A., Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T., Hart, R.G, Hori, M., Kakkar, A., Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K., Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019